Speciality Medicines Ltd.

As of March 31, 2026, Speciality Medicines Ltd. carries a market capitalization of 1.11B, placing it among publicly traded companies globally. Its enterprise value stands at 927.10M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Speciality Medicines Ltd. has 8.79M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Speciality Medicines Ltd. maintains a current ratio of 4.71, meaning it holds 4.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

These figures are as of the close on October 22, 2026.

As of March 31, 2026, Speciality Medicines Ltd. holds 245.46M in cash and equivalents against 66.42M in total debt, resulting in a net debt position of -179.03M. Total book value stands at 711.93M, with working capital of 700.86M providing operational flexibility.